| Literature DB >> 28360513 |
Tatiana-Danai Dimitriou1, Magdalini Tsolaki2.
Abstract
OBJECTIVE: The current review aims to evaluate the sensory stimulation interventions in terms of reducing sleeping disturbances in patients with dementia. The nonpharmacological interventions seem to be an efficient, inexpensive, and easy tool for family caregivers. Moreover, sleeping disorders increase caregivers' distress and may lead to hospitalization.Entities:
Keywords: dementia; nonpharmacological interventions; randomized controlled trials; review; sensory stimulation interventions; sleeping disturbances
Mesh:
Year: 2017 PMID: 28360513 PMCID: PMC5364002 DOI: 10.2147/CIA.S115397
Source DB: PubMed Journal: Clin Interv Aging ISSN: 1176-9092 Impact factor: 4.458
Previous trials included in current review
| Author (year) | Country | Participant | Method | Duration | Intervention | Outcome | Comment |
|---|---|---|---|---|---|---|---|
| Mishima et al | Japan | N=22 | Single-blind, crossover | Follow-up 2 weeks | 5,000–8,000 lux, 2 h/day 300 lux, 2 h/day for control group | Reduction in nightmares | No data from first period, unclear random sequence, reduced nightmares, no safe conclusions |
| Lyketsos et al | USA | N=15 | Single-blind, crossover | 4 weeks, follow-up | 10,000 lux morning 1 h/day, no information about control group. Follow-up 1 week | Differences in nocturnal sleep, improved sleep duration | No data from first period, unclear random sequence, no safe conclusions on the follow-up |
| Gasio et al | Switzerland | N=13, n=9 DDS, n=4 control group | Single-blind | 3 weeks | 400 lux morning + evening, control group same lux but red light | Promising findings | Dawn–Dusk simulator different from others, low risk of bias, but small sample size, no positive conclusion, no safe conclusions |
| Ancoli-Israel | USA | N=92, n=30 morning BLT, n=31 evening BLT, n=31 control group | Single-blind | 10 days | 2,500 lux 2 h/day, 300 lux 2 h/day for control group | No significant findings | AD patients, large sample size, positive conclusions |
| Dowling et al | USA | N=70, n=29 morning BLT, n=24 afternoon BLT, n=17 control group | Single-blind | 10 weeks | 2,500 lux 1 h/day, 5 days/week 150–200 lux control group, 1 h/day, 5 days/week 5 days/week | No significant findings | AD patients, large sample size, high risk of bias but no positive conclusions |
| Dowling et al | USA | N=50 | RCT | 10 weeks | 2,500 lux 1 h/day, 5 days/week 150–200 lux 1 h/day, 5 days/week for control group | No significant findings | AD patients, large sample size, high risk of bias but no positive conclusions |
| Riemersma-van der Lek et al | The Netherlands | N=189, n=45 randomized not to receive melatonin (double placebo), n=46 melatonin only, n=49 light only, n=49 light plus melatonin | Double-blind placebo-controlled randomized multicenter trial | 3.5 years | Plexiglass diffusers, 10,000 lux 9 h/day +2.5 mg melatonin. 400 lux 9 h/day for control group | Increased sleep duration for 27 s | Included other types of dementia low-risk bias, follow-up 6 months, large sample size, double-blind design. Positive results. Safe conclusions |
| Nowak | USA | N=20, n=10 blue–green light, n=10 dim red light | Experimental design | 14 days | 12,000 lux via cap visor (blue–green light), 30 m/day | Increased sleep quality and duration | Low risk of bias, but small sample. No safe conclusions |
| Burns et al | UK | N=46, n=26 standard light, n=22 BLT, 2 died | Interviews blinded, independent rater, blind to treatment condition | 2–3 weeks follow-up 4–8 weeks | BLT with 10,000 lux for 2 h/day, 100 lux for control group | No significant findings | High risk of bias, not reported all outcomes, no safe conclusions |
| McCurry et al | USA | N=132 | RCT | 8 weeks | BLT with Sun Ray Light Box 2,500 lux for 1 h/day, 6 months follow-up | Positive findings | Large sample size, low risk of bias, follow-up. Safe positive conclusions |
| Rodriguez et al | Spain | N=111, n=35 massage therapy, n=40 acupuncture therapy, and n=36 control group | RCT | 12 weeks | Massage: 5 days/week for 20 seconds and 5 months Acupuncture: Shenmen TF4, new seeds every 15 days | Positive findings | Large sample size Need of further research |
Abbreviations: AD, Alzheimer’s disease; BLT, bright light therapy; DDS, dawn and dusk simulation; RCT, randomized controlled trial.